Serial Number
85528296
Owner
Mission Therapeutics LimitedAttorney
Mark HarrisonFiling Date
Jan 30, 2012
MISSION THERAPEUTICS Trademark
Serial Number: 85528296
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
January 30, 2012
Registration Date
Not Registered
Goods & Services
Software; databases; electronically stored data and media for storing such data
Biological products for use in chemical and biological drug discovery, lead identification and diagnostics; biological products for therapeutic purposes; proteins for use in chemical and biological drug discovery, lead identification and diagnostics; therapeutic preparations; therapeutic preparations in the field of oncology and neurodegenerative diseases; anti-infectives; inhibitors; small molecule inhibitors
Chemical and proteins for chemical and biological drug discovery, lead identification and diagnostics; chemical reagents; proteins, enzymes
Bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification; diagnostic services, namely analytical laboratory services; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research and development services relating to inhibiting enzymes and proteins; research and development services relating to targeting therapies to individuals; research and development services relating to combining therapies for individuals; research and development relating to enzymes and proteins; research and development relating to reagents
